• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹泻型肠易激综合征中小肠细菌过度生长相关的十二指肠和直肠黏膜微生物群。

Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.

机构信息

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

J Gastroenterol Hepatol. 2020 May;35(5):795-805. doi: 10.1111/jgh.14910. Epub 2019 Nov 5.

DOI:10.1111/jgh.14910
PMID:31674052
Abstract

BACKGROUND AND AIM

Small intestinal bacterial overgrowth (SIBO) has been proposed as an etiologic factor in irritable bowel syndrome, particularly the diarrhea-predominant subtype (IBS-D). We aimed to identify potential intestinal microbial pattern in IBS-D patients with SIBO.

METHODS

Diarrhea-predominant irritable bowel syndrome patients fulfilling Rome III criteria were recruited and randomly divided into an exploratory cohort (57 cases) and a validation cohort (20 cases). SIBO was identified according to standard glucose hydrogen breath test. For 16S rRNA gene sequencing, samples of duodenal mucosa, duodenal fluid, rectal mucosa, and fresh feces were collected and performed. The α and β diversity, as well as differences in microbial composition and function, in SIBO and SIBO IBS-D subjects were evaluated.

RESULTS

The microbial diversity and composition obviously differed between SIBO and SIBO IBS-D in duodenal and rectal mucosa but not in duodenal fluid and fresh feces. For rectal mucosal microbiota, it displayed markedly reduced aerobe and Gram-negative bacteria and increased facultative anaerobe and Gram-positive bacteria, moreover, altered functions of microbial metabolism in SIBO IBS-D. Significantly higher rectal mucosa-related microbial dysbiosis index was observed in SIBO IBS-D, and a cut-off value at -0.37 had a sensitivity of 56.55% and specificity of 90.91% to identify the SIBO in IBS-D subjects.

CONCLUSIONS

Mucosal microbiota, rather than luminal bacteria, has a more apparent dysbiosis in SIBO IBS-D patients relative to those without SIBO. Rectal mucosa-associated microbiota may act as a potential predictor of SIBO in IBS-D patients.

摘要

背景与目的

小肠细菌过度生长(SIBO)被认为是肠易激综合征(IBS)的病因之一,尤其是腹泻为主型(IBS-D)。我们旨在确定伴有 SIBO 的 IBS-D 患者潜在的肠道微生物模式。

方法

符合罗马 III 标准的腹泻型肠易激综合征患者被招募并随机分为探索性队列(57 例)和验证性队列(20 例)。根据标准葡萄糖氢呼气试验确定 SIBO。进行 16S rRNA 基因测序,采集十二指肠黏膜、十二指肠液、直肠黏膜和新鲜粪便样本进行分析。评估 SIBO 和 SIBO IBS-D 患者的 α 和 β 多样性以及微生物组成和功能的差异。

结果

SIBO 和 SIBO IBS-D 患者的十二指肠和直肠黏膜微生物多样性和组成明显不同,但十二指肠液和新鲜粪便中则没有。对于直肠黏膜微生物群,其需氧菌和革兰氏阴性菌明显减少,兼性厌氧菌和革兰氏阳性菌增加,此外,SIBO IBS-D 患者的微生物代谢功能也发生了改变。在 SIBO IBS-D 患者中,直肠黏膜相关微生物失调指数明显升高,-0.37 的截断值对识别 IBS-D 患者中的 SIBO 具有 56.55%的敏感性和 90.91%的特异性。

结论

与无 SIBO 的患者相比,SIBO IBS-D 患者的黏膜微生物群而非腔细菌的失调更为明显。直肠黏膜相关微生物群可能是 IBS-D 患者 SIBO 的潜在预测因子。

相似文献

1
Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.腹泻型肠易激综合征中小肠细菌过度生长相关的十二指肠和直肠黏膜微生物群。
J Gastroenterol Hepatol. 2020 May;35(5):795-805. doi: 10.1111/jgh.14910. Epub 2019 Nov 5.
2
Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.共享黏膜相关微生物群在腹泻为主的肠易激综合征的十二指肠和直肠中的作用。
J Gastroenterol Hepatol. 2018 Jun;33(6):1220-1226. doi: 10.1111/jgh.14059. Epub 2018 Feb 26.
3
Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly abundance.小肠细菌过度生长主要通过增加丰度与腹泻型肠易激综合征相关。
Scand J Gastroenterol. 2019 Dec;54(12):1419-1425. doi: 10.1080/00365521.2019.1694067. Epub 2019 Nov 25.
4
Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.粪便细菌可预测利福昔明治疗腹泻型肠易激综合征的疗效。
Pharmacol Res. 2020 Sep;159:104936. doi: 10.1016/j.phrs.2020.104936. Epub 2020 May 26.
5
Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.肠易激综合征患者黏膜相关和粪便微生物群落组成的改变证据。
Sci Rep. 2020 Jan 17;10(1):593. doi: 10.1038/s41598-020-57468-y.
6
[Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].[便秘型和腹泻型肠易激综合征患者小肠细菌过度生长的评估]
Pol Merkur Lekarski. 2014 May;36(215):307-10.
7
The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.小肠细菌过度生长的患病率:小肠培养与肠易激综合征的关系。
Dig Dis Sci. 2012 May;57(5):1321-9. doi: 10.1007/s10620-012-2033-7. Epub 2012 Jan 20.
8
[Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].小肠细菌过度生长型肠易激综合征的临床特征及利福昔明疗效的初步研究
Zhonghua Yi Xue Za Zhi. 2016 Jun 28;96(24):1896-902. doi: 10.3760/cma.j.issn.0376-2491.2016.24.005.
9
A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.一项关于不同亚型肠易激综合征患者小肠细菌过度生长的荟萃分析。
J Gastroenterol Hepatol. 2020 Jun;35(6):922-931. doi: 10.1111/jgh.14938. Epub 2019 Dec 17.
10
Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome.了解腹泻型肠易激综合征患者的特定部位微生物模式,以进行准确的识别。
Microbiol Spectr. 2021 Dec 22;9(3):e0125521. doi: 10.1128/Spectrum.01255-21.

引用本文的文献

1
Bacteroides, Metabolites, and Lymphocytes: A Triad of Biomarkers in Small Intestinal Bacterial Overgrowth.拟杆菌、代谢产物与淋巴细胞:小肠细菌过度生长中的三联生物标志物
Food Sci Nutr. 2025 Jun 20;13(6):e70367. doi: 10.1002/fsn3.70367. eCollection 2025 Jun.
2
Chronic intestinal pseudo-obstruction: associations with gut microbiota and genes expression of intestinal serotonergic pathway.慢性肠道假性梗阻:与肠道微生物群和肠道 5-羟色胺能途径基因表达的关联。
BMC Microbiol. 2024 Feb 2;24(1):48. doi: 10.1186/s12866-024-03200-z.
3
Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats.
含有固定油和精油的益生菌制剂可改善大鼠小肠细菌过度生长诱导的肠道菌群失调。
Pharmaceuticals (Basel). 2023 Jul 22;16(7):1041. doi: 10.3390/ph16071041.
4
The emerging role of the small intestinal microbiota in human health and disease.小肠微生物群在人类健康和疾病中的新兴作用。
Gut Microbes. 2023 Jan-Dec;15(1):2201155. doi: 10.1080/19490976.2023.2201155.
5
Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.肠易激综合征亚组粪便与肠道黏膜微生物群的区别。
Dig Dis Sci. 2022 Dec;67(12):5580-5592. doi: 10.1007/s10620-022-07588-4. Epub 2022 Jul 25.
6
Immune Activation in Functional Dyspepsia: Bystander Becoming the Suspect.功能性消化不良中的免疫激活:旁观者成了嫌疑对象。
Front Neurosci. 2022 Apr 26;16:831761. doi: 10.3389/fnins.2022.831761. eCollection 2022.
7
Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.肠道菌群失调和小肠细菌过度生长作为肝硬化中肠道微生物群紊乱的独立形式。
World J Gastroenterol. 2022 Mar 14;28(10):1067-1077. doi: 10.3748/wjg.v28.i10.1067.
8
Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth.患有和未患有小肠细菌过度生长的系统性硬化症患者的粪便微生物群存在差异。
J Scleroderma Relat Disord. 2021 Oct;6(3):290-298. doi: 10.1177/23971983211032808. Epub 2021 Jul 24.
9
Mucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth.小肠细菌过度生长时黏膜相关微生物谱会发生改变。
Front Microbiol. 2021 Jul 30;12:710940. doi: 10.3389/fmicb.2021.710940. eCollection 2021.
10
Host/microbiota interactions in health and diseases-Time for mucosal microbiology!宿主/微生物群相互作用与健康和疾病——黏膜微生物组学的时代!
Mucosal Immunol. 2021 Sep;14(5):1006-1016. doi: 10.1038/s41385-021-00383-w. Epub 2021 Mar 26.